Tricho-rhino-phalangeal syndrome Type 1

Lore & Background

Individuals with TRPS I typically present with hair, facial features, and skeletal abnormalities. Hair abnormalities include sparse, thin, and slow-growing scalp hair. Distinctive facial characteristics include thick eyebrows, a broad nose with a rounded tip, large, protruding ears, a long, smooth philtrum, a thin upper lip, and small teeth that may be either reduced or increased in number. Affected individuals also typically exhibit short stature, brachydactyly (short fingers and toes), cone-shaped epiphyses, hip dysplasia, and other bone deformities.

Reader's Guide

TRPS I is caused by heterozygous pathogenic variants in the TRPS1 gene, which plays a role in the development of various tissues. The condition follows an autosomal dominant inheritance pattern, meaning a single copy of the altered gene can cause the disorder. Diagnosis is based on clinical evaluation, identification of characteristic physical features, and radiographic findings. Genetic testing can confirm mutations in the TRPS1 gene. Treatment is symptomatic and supportive, involving a multidisciplinary approach including orthopedic interventions to address skeletal deformities and improve mobility; dermatological care to manage hair abnormalities including topical minoxidil which has shown improvement in hair density and length. Other management approaches include endocrinological support to monitor growth and development, recombinant human growth hormone therapy has been used to improve height outcomes. Dental anomalies such as hypodontia or supernumerary teeth can also be addressed with appropriate orthodontic options.

Did You Know?

• The name TRPS I comes from 'tricho' (hair), 'rhino' (nose), and 'phalangeal' (fingers and toes).
• Topical minoxidil has shown improvement in hair density and length for affected individuals.

The Physical Signature

Individuals living with TRPS I carry a recognizable constellation of traits that span the scalp, face, and skeleton. On the head, hair tends to be sparse, fine, and slow to grow, giving a distinctive appearance. The facial profile is marked by thick, prominent eyebrows, a broad nasal bridge ending in a rounded tip, and ears that are large and project outward. The upper lip is thin, the philtrum is long and smooth, and the teeth are small—sometimes fewer in number than typical, sometimes more. Below the face, the skeletal picture includes short stature, shortened fingers and toes (brachydactyly), cone-shaped growth plates at the ends of bones, hip joint dysplasia, and additional bone deformities. Together, these features form a pattern that clinicians can identify through careful physical examination and imaging, making the syndrome visually and structurally distinct from other rare conditions.

The Genetic Blueprint

At its core, TRPS I is a single-gene disorder. A heterozygous pathogenic variant in the TRPS1 gene is sufficient to produce the condition. Because the inheritance follows an autosomal dominant pattern, only one altered copy of the gene is needed; a person does not need to inherit the variant from both parents. The TRPS1 gene itself plays a role in the development of multiple tissue types, which helps explain why the syndrome's effects are so widespread—touching hair, facial structure, and the entire skeletal framework. Diagnosis typically begins with a thorough clinical evaluation, where a physician identifies the characteristic physical features and orders radiographic imaging to confirm skeletal findings such as cone-shaped epiphyses. Genetic testing can then be used to pinpoint the specific mutation in TRPS1, providing definitive confirmation and enabling informed genetic counseling for families.

A Multidisciplinary Care Pathway

Because TRPS I affects so many body systems simultaneously, no single specialist can manage it alone. Treatment is symptomatic and supportive rather than curative, requiring a coordinated team. Orthopedic surgeons address skeletal deformities and work to preserve or improve mobility, particularly around the hips and fingers. Dermatologists manage the hair abnormalities, and topical minoxidil has shown measurable improvement in both hair density and length. Endocrinologists monitor growth and development throughout childhood, and recombinant human growth hormone therapy has been employed to help improve height outcomes. Dental and orthodontic specialists tackle the range of dental anomalies, whether teeth are missing (hypodontia) or present in excess (supernumerary teeth). This layered, team-based approach ensures that each affected system receives targeted attention while the individual's overall quality of life remains the central focus.

Decoding the Name

The very name of the condition is a compact map of its defining features. "Tricho" points to the hair—specifically the sparse, thin, slow-growing scalp hair that is a hallmark of the syndrome. "Rhino" refers to the nose, capturing the broad nasal bridge and rounded tip that give the face its characteristic look. "Phalangeal" highlights the fingers and toes, whose shortening (brachydactyly) and the cone-shaped epiphyses at their ends are among the most diagnostically significant skeletal findings. By encoding these three domains directly into the diagnosis, the nomenclature immediately communicates to any clinician which systems are involved. This naming convention also distinguishes TRPS I from other trichorhinophalangeal variants, underscoring that the specific combination of hair, nose, and digit abnormalities—along with the underlying TRPS1 mutation—defines this particular type within the broader family of rare genetic disorders.